A breakthrough pancreatic cancer drug won approval. They still struggle to access it | STAT
NEW9 days ago|Discuss (0)|Health
Article written by Angus Chen
A newly approved pancreatic cancer drug, Rasonque, is currently difficult for patients to access due to the closure of expanded access programs. Despite the excitement surrounding its approval, patients like Kelsey Solano face significant hurdles in securing coverage from insurance providers.
Read full story @ www.statnews.com/2026/09/08/pancreatic-cancer-patients-caught-beween-fda-drug-approval-insurance-coverage »
NewzGrade: 80 [B-]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
80B-
FDCBA
SPAG85
Coherent80
Objective75
Sourced90
Concise70
Graded by NewzGrade AI AI · provisional on September 08, 2026 at 11:31 PM
80B-
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 85 | 80 | 75 | 90 | 70 |
80B-grade breakdown
SPAG
85
Coherent
80
Objective
75
Sourced
90
Concise
70
As a news article, it presents factual information well, though some sections could benefit from clearer structure. It effectively highlights the challenges patients face in accessing a newly approved cancer drug.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
